Metabolic enzymes link morphine withdrawal with metabolic disorder

Cell Research

Volumn 17, Issue 9, 2007, Pages 741-743

  Jiang, Xi ^a   Li, Jing ^b   Ma, Lan ^a  

^a FUDAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE; MORPHINE; NARCOTIC AGENT; PROTEIN SUBUNIT; PYRUVATE DEHYDROGENASE COMPLEX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ANIMAL; ENERGY METABOLISM; ENZYMOLOGY; HUMAN; METABOLIC DISORDER; METABOLISM; MORPHINE ADDICTION; REVIEW; WITHDRAWAL SYNDROME;

ANIMALS; ENERGY METABOLISM; HUMANS; L-LACTATE DEHYDROGENASE; METABOLIC DISEASES; MORPHINE; MORPHINE DEPENDENCE; NADH DEHYDROGENASE; NARCOTICS; PROTEIN SUBUNITS; PYRUVATE DEHYDROGENASE COMPLEX; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 34548621261     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2007.75     Document Type: Review

References (12)

1. Chen XL, Lu G, Gong YX, et al. Expression changes of hippocampal energy metabolism enzymes contribute to behavioral abnormalities during chronic morphine treatment. Cell Res 2007; 17:689-700.
2. Mayers RM, Leighton B, Kilgour E. PDH kinase inhibitors: a novel therapy for Type II diabetes? Biochem Soc Trans 2005; 33:367-370.
3. Kobayashi K, Neely JR. Mechanism of pyruvate dehydrogenase activation by increased cardiac work. J MoI Cell Cardiol 1983; 15:369-382.
4. Bartnik BL, Hovda DA, Lee PW Glucose metabolism after traumatic brain injury: estimation of pyruvate carboxylase and pyruvate dehydrogenase flux by mass isotopomer analysis. J Neurotrauma 2007; 24:181-194.
5. Martin E, Rosenthal RE, Fiskum G. Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of wxidative stress. J Neurosci Res 2005; 79:240-247.
6. Holmquist L, Stuchbury G, Berbaum K, et al. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther 2007; 113:154-164
7. Trimmer PA, Borland MK. Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement. Antioxid Redox Signal 2005; 7:1101-1109
8. Mendoza-Fernandez V, Andrew RD, Barajas-Lopez C. ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampal slices. J Pharmacol Exp Ther 2000; 293:172-179.
9. Dodge PW, Takemori AE. Effects of morphine, nalnorphine and pentobarbital alone and combination on cerebral glycolytic substrates and cofactors of rats in vivo. Biochem Pharmacol 1972; 21:287-294.
10. Sherman AD, Mitchell CL. Effects of morphine and pain on brain intermediary metabolism. Neuropharmacology 1972; 11:871-877.
11. Akunne HC, Soliman KF. Hyperglycemic suppression of morphine withdrawal signs in the rat. Psychopharmacol 1988; 96:1-6.
12. Li Z, Wu CF, Pei G, Xu NJ. Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze: possible involvement of cholinergic system. Pharmacol Biochem Behav 2001; 68:507-513.